Chondros Dimitrios 4/A
4/A · HALOZYME THERAPEUTICS INC · Filed Feb 20, 2019
Insider Transaction Report
Form 4/AAmended
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2019-02-03$16.41/sh−2,536$41,616→ 31,566 total
Footnotes (1)
- [F1]On February 5, 2019, the reporting person filed a Form 4 reporting the disposition of 2,503 shares at a price of $16.12 per share representing the shares that were sold to pay minimum statutory tax withholding obligations due upon vesting of 6,165 restricted stock award shares. This report is being filed to correct the transaction code, the total number of shares sold, the price per share received upon disposition and the aggregate beneficial ownership of the reporting person as of February 3, 2019, which will be updated in Forms 4 filed after the date of this amendment.